The SYAI Ultra Continuous Glucose Monitoring (CGM) System is an ultra-light, AI-powered glucose monitoring solution that provides real-time glucose readings, trend analysis, and predictive alerts for up to 14 days. Designed for comfort and discretion, the sensor is approximately the size of a South African R1 coin and supports informed glucose management for people living with diabetes.
Or pay over multiple months interest-free, using your existing credit card. For orders over R7,000.00
No results found.
The SYAI Ultra Continuous Glucose Monitoring (CGM) System is an advanced AI-powered glucose monitoring solution developed in Singapore and approved by SAHPRA for use in South Africa. The ultra-light sensor continuously measures glucose levels in real time, providing people living with diabetes with valuable insights into glucose trends, patterns, and fluctuations throughout the day and night.
With a Mean Absolute Relative Difference (MARD) of approximately 8.1%, factory calibration, and a wear period of up to 14 days, the SYAI Ultra offers accurate glucose monitoring without routine finger-prick calibration. The compact sensor is approximately the size of a South African R1 coin, making it discreet and comfortable for everyday wear.
Apply the SYAI Ultra sensor to the back of the upper arm according to the manufacturer’s instructions. Pair the sensor with the SYAI mobile application and allow the system warm-up period to complete. Once activated, glucose readings, trend information, alerts, and reports are automatically displayed within the app. Users may share glucose information with caregivers and healthcare professionals through the SYAI ecosystem.
The SYAI Ultra CGM System measures glucose levels in interstitial fluid and may differ from blood glucose readings obtained via finger-prick testing. If symptoms do not match the glucose reading displayed by the device, a blood glucose meter should be used to confirm glucose levels before making treatment decisions.
Certain medications, including high doses of Vitamin C (ascorbic acid), paracetamol, ibuprofen, aspirin, and salicylates, may interfere with glucose readings. Always consult the product instructions and your healthcare professional regarding potential interactions.
People living with diabetes should discuss CGM use with their healthcare provider to ensure appropriate interpretation of glucose data and treatment adjustments.
Medical Aid Status: Discovery Health Technology Assessment (HTA) approval is currently pending. Coverage may vary between medical schemes. Out-of-pocket payment may apply.
Only logged in customers who have purchased this product may leave a review.
Our goal is to help people in the best way possible. this is a basic principle in every case and cause for success.Â
Sign up to our newsletter
The CDE Pharmacy (Pty) Ltd
T/A The Centre Pharmacy
Pharmacy Nr: Y03847
81 Central Street, Houghton Estate
P.O.Box 2900, Saxonwold, 2132, South Africa
Tel: +27117126000
Fax: +27117286661
Responsible Pharmacist: Imraan Ahmed Bismilla
(P00935)
Reviews
There are no reviews yet.